BiotechTube
TREKKA Therapeutics

TREKKA Therapeutics

Cambridge, United States· Est.
trekkatherapeutics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $30M

Overview

TREKKA Therapeutics is an early-stage biotech focused on a polymeric drug delivery platform called CAPRO™. The platform aims to solve critical formulation bottlenecks for poorly soluble drugs and biologics, thereby improving efficacy and development success rates. The company operates as a development partner for pharmaceutical companies, offering services from engineering and prototyping to GMP manufacturing transfer. Based on the available information, it appears to be a pre-revenue, platform-focused entity seeking collaborative partnerships.

Drug Delivery

Technology Platform

CAPRO™, a novel polymeric biomaterial excipient platform designed to enhance drug solubility, stability, release kinetics, and bioavailability for both biologics and small molecules.

Funding History

2
Total raised:$30M
Series A$25M
Seed$5M

Opportunities

The large and growing market of poorly soluble drug candidates and complex biologics creates a significant need for enabling delivery technologies.
TREKKA's partnership model offers a capital-efficient path to validate its platform and generate revenue through collaboration deals, potentially leading to lucrative licensing agreements or an acquisition.

Risk Factors

The company faces high technical risk that its platform may not perform broadly as claimed, and intense commercial risk competing against established drug delivery players and technologies.
Its pre-revenue status and dependence on securing partnerships create substantial financial and execution risk.

Competitive Landscape

TREKKA competes in a crowded field with large chemical suppliers, established CDMOs with formulation expertise, and numerous biotech startups focused on novel drug delivery technologies. Differentiation will require demonstrating clear superiority in efficacy, versatility, or cost-effectiveness.

More companies in Drug Delivery & Formulation →More companies in United States →